Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07060495 · ClinicalTrials.gov registry record · Phase 3
RADA16 for Adult Tonsillectomy
A Phase 3 study of Postoperative Pain, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 134
- Enrollment target
- 2
- Study locations
NCT07060495: Recruiting Phase 3 study of Postoperative Pain, sponsored by Rutgers, The State University of New Jersey.
NCT07060495 is a Phase 3 study of Postoperative Pain that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 134 participants, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (42% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07060495, a Phase 3 study of Postoperative Pain, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 134 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following tonsillectomy procedures. Researchers will compare application of device RADA16 to application of no device to see if RADA16 works to treat post tonsillectomy hemorrhage. Participants will: * Undergo tonsillectomy procedure. * Receive and fill out a survey sent via email every 2 days following their procedure for 15 days and track their symptoms.
Primary Outcome
Pain assessed via the pain visual analog scale (VAS). The primary outcome measure will be assessed via online survey on post-operative day one then subsequently every other day until post-operative day fifteen.
Conditions Studied
Interventions
- DEVICE RADA16 hydrogel
Study Locations (2)
New Jersey
- Cooperman Barnabas Medical Center - Livingston
- University Hospital - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2025-09-12 |
| Est. Completion | 2026-09-01 |
| Phase | Phase 3 |
What NCT07060495 shows while recruiting
NCT07060495 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 231-participant average among 120 other Postoperative Pain trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which RADA16 hydrogel is the first listed.
NCT07060495 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT07060495 about?
NCT07060495 is a clinical study titled "RADA16 for Adult Tonsillectomy". The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following tonsillectomy procedures. Researchers will compare application of device RADA16 to application of no device to see if RADA16 works to treat post tonsillectomy...
What is the current status of trial NCT07060495?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 134 participants. The study started on 2025-09-12. Estimated completion is 2026-09-01.
What conditions does trial NCT07060495 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT07060495?
The interventions under investigation include: RADA16 hydrogel (DEVICE).
Who is sponsoring clinical trial NCT07060495?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07060495 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07060495's enrollment target sits among peer trials
134 36th of 120 higher than 85 of 120 other Postoperative Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postoperative Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of TLC590 for Postsurgical Pain Following Bunionectomy
RECRUITING · Phase 3
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Methadone in TKA for Post-op Pain and Opioid Reduction
RECRUITING · Phase 3
-
Methadone in THA for Post-op Pain and Opioid Reduction
RECRUITING · Phase 3
-
Perioperative Lidocaine and Ketamine in Abdominal Surgery
ACTIVE NOT RECRUITING · Phase 3
-
Comparison of the Safety of Q8003 Versus Morphine Equivalent Doses of Its Components (Oxycodone and Morphine) in Bunionectomy Patients
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI